LONGO PETER F.

SEC source: 0001493152-26-030430 · ownership.xml · derivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 131,870

Underlying: Common Stock · 131,870 shares

Expires 2036-06-25

F1 · shares: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · derivative.exercise_date: Such option was received as compensation for the reporting person's services as a member of the board of directors of the issuer and its exercise is subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such option and the shares of common stock issuable upon exercise thereof until its issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-023225 · ownership.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,916

F1 · shares: Open market purchase by the reporting person of 10,000 shares of common stock, par value $0.001 per share.

SEC source: 0001493152-26-003478 · ownership.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,916

F1 · shares: Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

F1 · price: Such shares of common stock were received as compensation for the reporting person's services as a member of the board of directors of the issuer and are subject to quarterly vesting over a period of twelve months from the date of grant. The reporting person disclaims beneficial ownership of such shares until their issuance pursuant to the issuer's 2025 Equity Incentive Plan.

SEC source: 0001493152-26-001902 · ownership.xml · nonDerivative · entry 2

LONGO PETER F. · CIK 0001508592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,041

F4 · shares: Open market purchase by the reporting person of 5,000 shares of Common Stock.

SEC source: 0001493152-26-001902 · ownership.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,041

F1 · shares: Open market purchase by the reporting person of 26,041 shares of common stock, par value $0.001 per share (the "Common Stock").

F2 · price: Reflects the weighted average price of the shares purchased on the open market in multiple transactions on December 19, 2025 at prices ranging from $1.59 to $1.69 per share, inclusive.

F3 · price: The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.

SEC source: 0001508592-25-000010 · primary_doc.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,917.48

F1 · shares: The Board approved the issuance of these shares pending approval of a future equity incentive plan. The shares have not been issued and will not be issued until shareholders approve a future equity incentive plan. Mr. Longo disclaims beneficial ownership of these shares.

F1 · price: The Board approved the issuance of these shares pending approval of a future equity incentive plan. The shares have not been issued and will not be issued until shareholders approve a future equity incentive plan. Mr. Longo disclaims beneficial ownership of these shares.

F1 · balance_after: The Board approved the issuance of these shares pending approval of a future equity incentive plan. The shares have not been issued and will not be issued until shareholders approve a future equity incentive plan. Mr. Longo disclaims beneficial ownership of these shares.

SEC source: 0001493152-26-001897 · ownership.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

F1 · date: This Form 4 amendment is being filed by the reporting person in order to correct the transaction date in the Form 4 filed by the reporting person with the U.S. Securities and Exchange Commission ("SEC") on July 1, 2025 (the "Original Form 4"). On June 27, 2025, the board of directors of the issuer approved the grant of the shares of the issuer's common stock, par value $0.001 per share (the "Common Stock"), reported in the Original Form 4. Accordingly, the date in Column 2 of the Original Form 4 is hereby amended to June 27, 2025.

F2 · balance_after: This Form 4 amendment is also being filed by the reporting person in order to correct the total number of shares of Common Stock beneficially owned and reported in the Original Form 4, which erroneously included 11,917.48 shares of Common Stock issuable upon exercise of stock options previously awarded to the reporting person and reported in Table II of the Form 4 filed by the reporting person with the SEC on June 17, 2025. Accordingly, the number of shares of Common Stock reported in Column 5 of Table I of the Original Form 4 is hereby amended to 40,000 shares of Common Stock.

SEC source: 0001508592-25-000009 · primary_doc.xml · derivative · entry 6

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,917.48

Underlying: Common Stock · 1,415.09 shares

Expires 2035-06-17

F11 · shares: On June 17, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $10.60 per share (the trading price for the last business day before the grant date). Therefore, on June 17, 2025, 1,415.09 options were granted to the reporting person.

F12 · derivative.exercise_date: The options were granted on June 17, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F12 · derivative.expiration_date: The options were granted on June 17, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F11 · derivative.underlying_shares: On June 17, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $10.60 per share (the trading price for the last business day before the grant date). Therefore, on June 17, 2025, 1,415.09 options were granted to the reporting person.

SEC source: 0001508592-25-000008 · primary_doc.xml · derivative · entry 5

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,023.92

Underlying: Common Stock · 22,058.82 shares

Expires 2035-05-15

F9 · shares: On May 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.68 per share (the trading price for the last business day before the grant date). Therefore, on May 15, 2025, 22,058.82 options were granted to the reporting person.

F10 · derivative.exercise_date: The options were granted on May 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F10 · derivative.expiration_date: The options were granted on May 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F9 · derivative.underlying_shares: On May 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.68 per share (the trading price for the last business day before the grant date). Therefore, on May 15, 2025, 22,058.82 options were granted to the reporting person.

SEC source: 0001508592-25-000009 · primary_doc.xml · derivative · entry 5

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,502.39

Underlying: Common Stock · 2,205.88 shares

Expires 2035-05-15

F13 · derivative.exercise_price: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F9 · shares: On May 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.68 per share (the trading price for the last business day before the grant date). Therefore, on May 15, 2025, 22,058.82 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F10 · derivative.exercise_date: The options were granted on May 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F10 · derivative.expiration_date: The options were granted on May 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F9 · derivative.underlying_shares: On May 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.68 per share (the trading price for the last business day before the grant date). Therefore, on May 15, 2025, 22,058.82 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · derivative.underlying_shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F13 · balance_after: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

SEC source: 0001508592-25-000007 · primary_doc.xml · derivative · entry 4

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,965.1

Underlying: Common Stock · 26,787.71 shares

Expires 2035-04-15

F7 · shares: On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person.

F8 · derivative.exercise_date: The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F8 · derivative.expiration_date: The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F7 · derivative.underlying_shares: On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person.

SEC source: 0001508592-25-000008 · primary_doc.xml · derivative · entry 4

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,965.1

Underlying: Common Stock · 26,785.71 shares

Expires 2035-04-15

F7 · shares: On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person.

F8 · derivative.exercise_date: The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F8 · derivative.expiration_date: The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F7 · derivative.underlying_shares: On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person.

SEC source: 0001508592-25-000009 · primary_doc.xml · derivative · entry 4

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,296.51

Underlying: Common Stock · 2,678.57 shares

Expires 2035-04-15

F13 · derivative.exercise_price: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F7 · shares: On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F8 · derivative.exercise_date: The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F8 · derivative.expiration_date: The options were granted on April 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F7 · derivative.underlying_shares: On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date). Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · derivative.underlying_shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F13 · balance_after: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

SEC source: 0001508592-25-000005 · primary_doc.xml · derivative · entry 3

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,179.39

Underlying: Common Stock · 14,018.69 shares

Expires 2035-03-15

F5 · shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

F6 · derivative.exercise_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F6 · derivative.expiration_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F5 · derivative.underlying_shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

SEC source: 0001508592-25-000007 · primary_doc.xml · derivative · entry 3

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,179.39

Underlying: Common Stock · 14,018.69 shares

Expires 2035-03-15

F5 · shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

F6 · derivative.exercise_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F6 · derivative.expiration_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F5 · derivative.underlying_shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

SEC source: 0001508592-25-000008 · primary_doc.xml · derivative · entry 3

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,179.39

Underlying: Common Stock · 14,018.69 shares

Expires 2035-03-15

F5 · shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

F6 · derivative.exercise_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F6 · derivative.expiration_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F5 · derivative.underlying_shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person.

SEC source: 0001508592-25-000009 · primary_doc.xml · derivative · entry 3

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,617.93

Underlying: Common Stock · 1,401.87 shares

Expires 2035-03-15

F13 · derivative.exercise_price: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F5 · shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F6 · derivative.exercise_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F6 · derivative.expiration_date: The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F5 · derivative.underlying_shares: On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date). Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · derivative.underlying_shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F13 · balance_after: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

SEC source: 0001508592-25-000004 · primary_doc.xml · derivative · entry 2

LONGO PETER F. · CIK 0001508592 · Director · CEO, President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,160.7

Underlying: Common Stock · 10,638.3 shares

Expires 2035-02-15

F3 · shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

F4 · derivative.exercise_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F4 · derivative.expiration_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F3 · derivative.underlying_shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

SEC source: 0001508592-25-000005 · primary_doc.xml · derivative · entry 2

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,160.7

Underlying: Common Stock · 10,638.3 shares

Expires 2035-02-15

F3 · shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

F4 · derivative.exercise_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F4 · derivative.expiration_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F3 · derivative.underlying_shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

SEC source: 0001508592-25-000007 · primary_doc.xml · derivative · entry 2

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,160.7

Underlying: Common Stock · 10,638.3 shares

Expires 2035-02-15

F3 · shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

F4 · derivative.exercise_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F4 · derivative.expiration_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F3 · derivative.underlying_shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

SEC source: 0001508592-25-000008 · primary_doc.xml · derivative · entry 2

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,160.7

Underlying: Common Stock · 10,638.3 shares

Expires 2035-02-15

F3 · shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

F4 · derivative.exercise_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F4 · derivative.expiration_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F3 · derivative.underlying_shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person.

SEC source: 0001508592-25-000009 · primary_doc.xml · derivative · entry 2

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,216.07

Underlying: Common Stock · 1,063.83 shares

Expires 2035-02-15

F13 · derivative.exercise_price: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F3 · shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F4 · derivative.exercise_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F4 · derivative.expiration_date: The options were granted on February 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F3 · derivative.underlying_shares: On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date). Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · derivative.underlying_shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F13 · balance_after: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

SEC source: 0001508592-25-000003 · primary_doc.xml · derivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director · CEO, President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,522.4

Underlying: Common Stock · 9,202.45 shares

Expires 2035-01-15

F1 · shares: On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date). Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person.

F2 · derivative.exercise_date: The options were granted on January 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F2 · derivative.expiration_date: The options were granted on January 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F1 · derivative.underlying_shares: On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date). Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person.

SEC source: 0001508592-25-000004 · primary_doc.xml · derivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director · CEO, President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,522.4

Underlying: Common Stock · 9,202.45 shares

Expires 2035-01-15

F1 · shares: On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date). Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person.

F2 · derivative.exercise_date: The options were granted on January 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F2 · derivative.expiration_date: The options were granted on January 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F1 · derivative.underlying_shares: On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date). Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person.

SEC source: 0001508592-25-000005 · primary_doc.xml · derivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,522.4

Underlying: Common Stock · 9,202.45 shares

Expires 2035-01-15

F1 · shares: On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date). Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person.

F2 · derivative.exercise_date: The options were granted on January 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F2 · derivative.expiration_date: The options were granted on January 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F1 · derivative.underlying_shares: On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date). Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person.

SEC source: 0001508592-25-000007 · primary_doc.xml · derivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,522.4

Underlying: Common Stock · 9,202.45 shares

Expires 2035-01-15

F1 · shares: On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date). Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person.

F2 · derivative.exercise_date: The options were granted on January 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F2 · derivative.expiration_date: The options were granted on January 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F1 · derivative.underlying_shares: On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date). Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person.

SEC source: 0001508592-25-000008 · primary_doc.xml · derivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,522.4

Underlying: Common Stock · 9,202.45 shares

Expires 2035-01-15

F1 · shares: On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date). Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person.

F2 · derivative.exercise_date: The options were granted on January 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F2 · derivative.expiration_date: The options were granted on January 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F1 · derivative.underlying_shares: On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date). Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person.

SEC source: 0001508592-25-000009 · primary_doc.xml · derivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,152.24

Underlying: Common Stock · 920.25 shares

Expires 2035-01-15

F13 · derivative.exercise_price: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F1 · shares: On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date). Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F2 · derivative.exercise_date: The options were granted on January 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F2 · derivative.expiration_date: The options were granted on January 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F1 · derivative.underlying_shares: On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date). Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

F13 · derivative.underlying_shares: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

F13 · balance_after: Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

SEC source: 0001493152-24-050441 · ownership.xml · derivative · entry 2

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,869.57

Underlying: Common Stock · 10,869.57 shares

Expires 2034-12-15

F1 · shares: On December 15, 2024, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.38 per share (the trading price for the last business day before the grant date). Therefore, on December 15, 2024, 10,791.37 options were granted to the reporting person.

F2 · derivative.exercise_date: The options were granted on December 15, 2024 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F2 · derivative.expiration_date: The options were granted on December 15, 2024 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F1 · derivative.underlying_shares: On December 15, 2024, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.38 per share (the trading price for the last business day before the grant date). Therefore, on December 15, 2024, 10,791.37 options were granted to the reporting person.

F1 · balance_after: On December 15, 2024, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.38 per share (the trading price for the last business day before the grant date). Therefore, on December 15, 2024, 10,791.37 options were granted to the reporting person.

SEC source: 0001493152-24-047513 · ownership.xml · derivative · entry 1

LONGO PETER F. · CIK 0001508592 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,450.38

Underlying: Common Stock · 11,450.38 shares

Expires 2034-11-11

F1 · shares: On November 11, 2024, the reporting person received a monthly-grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.31 per share. Therefore, on November 11, 2024, 11,450.38 options were granted to the reporting person.

F2 · derivative.exercise_date: The options were granted on November 11, 2024 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F2 · derivative.expiration_date: The options were granted on November 11, 2024 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

F1 · derivative.underlying_shares: On November 11, 2024, the reporting person received a monthly-grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.31 per share. Therefore, on November 11, 2024, 11,450.38 options were granted to the reporting person.

F1 · balance_after: On November 11, 2024, the reporting person received a monthly-grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.31 per share. Therefore, on November 11, 2024, 11,450.38 options were granted to the reporting person.

SEC source: 0001225208-13-007562 · doc4.xml · derivative · entry 4

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2014-01-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-13-007562 · doc4.xml · nonDerivative · entry 2

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,861.2055

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in mulitple transactions at prices ranging from $93.12 to $93.13. Upon request, UTC will provide full information as to the shares sold at each separate price.

SEC source: 0001225208-13-007562 · doc4.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,861.2055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-13-004559 · doc4.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,861.2055

SEC source: 0001225208-13-003972 · doc4.xml · derivative · entry 6

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 3,800 shares

Expires 2014-01-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-13-003972 · doc4.xml · nonDerivative · entry 4

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,338.2055

SEC source: 0001225208-13-003972 · doc4.xml · nonDerivative · entry 3

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,138.2055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-13-003972 · doc4.xml · nonDerivative · entry 2

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,338.2055

SEC source: 0001225208-13-003972 · doc4.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,119.76

F1 · shares: The reporting person acquired 2,241 shares of UTC common stock and 747 UTC deferred stock units upon the vesting of performance share units (PSUs) previously awarded on January 4, 2010 to the reporting person under the UTC 2005 Long-Term Incentive Plan. Each PSU has a value equal to one share of UTC common stock. The PSUs vested solely upon achievement of pre-established performance targets for UTC's earnings per share and total shareholder return over a three-year performance period. The reporting person previously elected to defer receipt of a portion of the actual shares of common stock that otherwise would be received upon the vesting of these PSUs and in respect of that portion of the vested units acquired instead deferred stock units that settle exclusively in shares and are included in Table I as common stock equivalents. Each deferred stock unit has a value equal to one share of UTC common stock.

SEC source: 0001225208-13-002068 · doc4.xml · derivative · entry 5

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,800

Underlying: Common Stock · 10,000 shares

Expires 2014-01-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-13-002068 · doc4.xml · nonDerivative · entry 2

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,131.76

F1 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.47 to $88.50. Upon request, UTC will provide full information as to the shares sold at each separate price.

SEC source: 0001225208-13-002068 · doc4.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,131.76

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-13-000875 · doc4.xml · derivative · entry 3

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,600

Underlying: Common Stock · 12,600 shares

Expires 2023-01-01

F1 · balance_after: The reporting person was also awarded 3,080 performance share units (PSUs) under the UTC Long Term Incentive Plan. Each PSU has a value equal to one share of UTC common stock. These PSUs vest solely upon achievement of pre-established performance targets for UTC's earnings per share and total shareholder return over a three year time period.

SEC source: 0001225208-12-024101 · doc4.xml · derivative · entry 4

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2013-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-12-024101 · doc4.xml · nonDerivative · entry 2

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,013.0565

F1 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.893 to $79.911. Upon request, UTC will provide full information as to the shares sold at each separate price.

SEC source: 0001225208-12-024101 · doc4.xml · nonDerivative · entry 1

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,013.0565

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-12-018346 · doc4.xml · derivative · entry 7

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 10,800 shares

Expires 2013-01-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-12-018346 · doc4.xml · nonDerivative · entry 5

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,892.2848

SEC source: 0001225208-12-018346 · doc4.xml · nonDerivative · entry 4

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,327.2848

SEC source: 0001225208-12-018346 · doc4.xml · nonDerivative · entry 3

LONGO PETER F. · CIK 0001508592 · Vice President, Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,308.2848